CD274 and hepatocellular carcinoma: Importantly, the enhanced efficacy of combining CAR-M activity with PD-L1 blockade demonstrates a translatable strategy to counter adaptive immune evasion in advanced HCC, positioning this approach as a promising therapeutic platform worthy of further investigation.